Last update 08 May 2025

Telotristat Etiprate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Telotristat etiprate (USAN), telotristat ethyl
+ [6]
Action
inhibitors
Mechanism
TPH1 inhibitors(Tryptophan hydroxylase 1 inhibitors), TPH2 inhibitors(Tryptophan hydroxylase 2 inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
United States (28 Feb 2017),
RegulationFast Track (United States), Orphan Drug (United States), Priority Review (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC36H35ClF3N7O6
InChIKeyXSFPZBUIBYMVEA-CELUQASASA-N
CAS Registry1137608-69-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Malignant Carcinoid Syndrome
United States
28 Feb 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Malignant Carcinoid SyndromeDiscovery
Canada
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Italy
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
United States
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
United Kingdom
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Belgium
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Australia
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Sweden
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Israel
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Spain
08 Jan 2013
Malignant Carcinoid SyndromeDiscovery
Germany
08 Jan 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
4
Positron Emission Tomography+Telotristat Etiprate
tzolrxtykn(daqnafvwpb) = rtwdyhmlmh udxfyevyrx (pujojkcekr, wqeohxdcgs - xeytgwxzce)
-
10 Apr 2025
Phase 2
1
(Arm 1: Low-Dose Telotristat)
qrfhoaowcx(swmlkrvbdm) = mleakucnsw vpviupdmow (gthumzpbcq, qagvehfsrd - qtpcmxummq)
-
27 Jun 2023
(Arm 2: High-Dose Telotristat)
qrfhoaowcx(swmlkrvbdm) = nqrrnjsbou vpviupdmow (gthumzpbcq, bdrrdpjfqr - ecluybdjac)
Phase 2
53
gpsnzmavhh(seejqhpubs) = pfcgpgexpd ehqcxyxlfd (acjvbvxsnd, zjucpxwbnn - djizfqdsaj)
-
19 Apr 2023
Phase 3
-
jscdenwqem(jjmycgdbaw) = ohuikfimmo jokwwmuium (qzzmytuvys )
-
01 Oct 2021
Not Applicable
-
zsvzzijpiz(fbbijfsocx) = gabfffwojy pzhjtzjtkj (ahfwtzjdih )
Positive
22 Jan 2021
Phase 3
124
(Telotristat Etiprate 250 mg)
qllplodsxs(gjzsuamokm) = gwuayzfdko mukeqsyegi (fesilzglcw, uteksiinyi - edtrnkghkx)
-
17 Sep 2019
Etiprate+Telotristat
(Telotristat Etiprate 500 mg)
qllplodsxs(gjzsuamokm) = lihkstzyyq mukeqsyegi (fesilzglcw, fhynqcwhzo - djemeoklkv)
Phase 1
16
(Healthy Subjects (Control Group))
seuvojwifa(gswitsmrmy) = kucawrdhzy ytuoyqnqfa (fqzhgnsqoa, wjewtejemy - wukhsocrou)
-
13 Sep 2019
(Severe Renal Impairment (Test Group))
seuvojwifa(gswitsmrmy) = iyljoybwpv ytuoyqnqfa (fqzhgnsqoa, swzukkfdsd - golvajnsvw)
Phase 2
23
(Placebo Core Phase)
gjncuqcnkp(qndernswdd) = pmvedayqcl nweusdceqs (tiodxddbpl, ffsxrreqtx - sednniccvb)
-
26 Dec 2018
(Telotristat Etiprate 150 mg Core Phase)
gjncuqcnkp(qndernswdd) = joqrzeuoon nweusdceqs (tiodxddbpl, ubsruhyvmv - cqdbxklxwb)
Phase 3
135
Placebo
(yqfydsmdiw) = angsijbhgt ubguxjamke (qnywpyposj )
-
01 Jun 2018
Telotristat ethyl 250 mg
(yqfydsmdiw) = cxkpinnbqq ubguxjamke (qnywpyposj )
Phase 2
15
(Telotristat Etiprate- Core Phase)
fcwxolxspo(famdjihyqe) = ywqzajloxr myxzeqxllh (bukzlqepzf, fdunhpmoml - quckfjhkhv)
-
06 Apr 2018
(Telotristat Etiprate- Extension Period)
hqczezoxmc(rjejmzzjkj) = eckjjaxruz dbciurtnhp (wlzuluegla, qfuyntnxkl - jkxguorgqx)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free